Cardiometabolic
Glempozin 25mg
- Glempozin 25mg
- Active Ingredient: Empagliflozin 10/25 mg
- Product Overview
- Glempozin contains Empagliflozin, an SGLT2 inhibitor used in the management of type 2 diabetes mellitus and heart failure
- Empagliflozin works by reducing glucose reabsorption in the kidneys, allowing excess glucose to be eliminated through urine.
- Indications
- Glempozin may be prescribed for:
- Type 2 diabetes mellitus
- Cardiovascular risk reduction in diabetic patients
- Heart Failure
- CKD with or without Diabetes
In Stock
Clinical Grade
